Evaluation of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasis

被引：0
|
作者：
Schumacher, W. A. [1 ]
Bostwick, J. S. [1 ]
Stewart, A. B. [1 ]
Xin, B. [1 ]
Wong, P. C. [1 ]
机构：
[1] Bristol Myers Squibb, Thrombosis Res, Pennington, NJ USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-202
引用
收藏
页码：1001 / 1001
页数：1
相关论文
共 50 条
  • [21] Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro
    Jiang, Xiaosui
    Crain, Earl J.
    Luettgen, Joseph M.
    Schumacher, William A.
    Wong, Pancras C.
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (04) : 780 - 782
  • [22] Apixaban, an oral direct factor Xa inhibitor, inhibits human clot-bound factor Xa activity in vitro
    Jiang, Xiaosui
    Crain, Earl J.
    Schumacher, William A.
    Wong, Pancras C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E137 - E137
  • [23] Evaluation of the oral direct factor Xa inhibitor - betrixaban
    Palladino, Michael
    Merli, Geno
    Thomson, Lynda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2013, 22 (11) : 1465 - 1472
  • [24] Thrombosis prophylaxis with direct factor-Xa-inhibitor-effective and easier
    Vetter, Christine
    HANDCHIRURGIE MIKROCHIRURGIE PLASTISCHE CHIRURGIE, 2008, 40 (04) : 282 - 282
  • [25] Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban—an oral, direct and selective factor Xa inhibitor
    Richard C. Becker
    Hongqiu Yang
    Yuchen Barrett
    Puneet Mohan
    Jessie Wang
    Lars Wallentin
    John H. Alexander
    Journal of Thrombosis and Thrombolysis, 2011, 32 : 183 - 187
  • [26] Chromogenic laboratory assays to measure the factor Xa-inhibiting properties of apixaban-an oral, direct and selective factor Xa inhibitor
    Becker, Richard C.
    Yang, Hongqiu
    Barrett, Yuchen
    Mohan, Puneet
    Wang, Jessie
    Wallentin, Lars
    Alexander, John H.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (02) : 183 - 187
  • [27] Arterial antithrombotic effect of apixaban, a direct factor Xa inhibitor, in combination with aspirin and/or clopidogrel in rabbits
    Wong, Pancras C.
    Watson, Carol A.
    Crain, Earl J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) : E102 - E102
  • [28] EFFECT OF FAMOTIDINE ON THE PHARMACOKINETICS OF APIXABAN, AN ORAL DIRECT FACTOR Xa INHIBITOR, IN HEALTHY SUBJECTS.
    Uprett, Vijay V.
    Song, Yan
    Wang, Jessie
    Farmer, Mathew
    Pursley, Janica M.
    Li, Tong
    Frost, Charles E.
    LaCreta, Frank P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1117 - 1117
  • [29] Apixaban, an oral, direct and highly selective factor Xa inhibitor:: in vitro, antithrombotic and antihemostatic studies
    Wong, P. C.
    Crain, E. J.
    Xin, B.
    Wexler, R. R.
    Lam, P. Y. S.
    Pinto, D. J.
    Luettgen, J. M.
    Knabb, R. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (05) : 820 - 829
  • [30] Comparison of YM150, an oral, direct factor Xa inhibitor, with other antithrombotic agents in thrombosis models
    Saitoh, Minori
    Kaku, Seiji
    Iwatsuki, Yoshiyuki
    Sasamata, Masao
    Miyata, Keiji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 213P - 213P
12345